Similar results were described by Kim and coworkers when they reported that approximately 72% of glaucoma patients displayed a high concentration of tear MMP-9 (over 40 ng/mL); however, when studying a control group of 47 healthy subjects, only about 32% of them showed an increase in this biomarker [48]. The gene discussed is MMP9; the disease is glaucoma.